Moderna stock popped Wednesday after the CDC recommended the company's RSV vaccine for at-risk adults in their 50s.

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

The vote offers a sigh of relief to doctors and public health experts worried about vaccine skepticism creeping into policymaking.

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...

When you catch a cold or the flu, a sore throat is often a symptom, making swallowing and talking uncomfortable. With ...

Primary Source JAMA Source Reference: Surie D, et al "RSV vaccine effectiveness against hospitalization among US adults 60 years and older" JAMA 2024; DOI: 10.1001/jama.2024.15775.

June 17, 2025 – The FDA has expanded the use of Moderna's respiratory syncytial virus (RSV) shot to all adults, with some limits on who can get it. First approved in 2024 for people 60 or older ...

The Food and Drug Administration (FDA) has expanded the approval of mResvia (respiratory syncytial virus [RSV] vaccine) to include active immunization in individuals 18 through 59 years of age who ...